-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development
Tahereh Taheri, Sima Rafati
Review Article: Clinical Investigation
-
Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development
Tahereh Taheri, Sima Rafati
Review Article: Clinical Investigation
-
Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development
Tahereh Taheri, Sima Rafati
Review Article: Clinical Investigation
-
Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development
Tahereh Taheri, Sima Rafati
Review Article: Clinical Investigation
-
Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development
Tahereh Taheri, Sima Rafati
Review Article: Clinical Investigation
-
Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development
Tahereh Taheri, Sima Rafati
Review Article: Clinical Investigation
-
Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development
Tahereh Taheri, Sima Rafati
Review Article: Clinical Investigation
-
Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development
Tahereh Taheri, Sima Rafati
Review Article: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
Therapeutic potential of histone deacetylase inhibitors for breast cancer
Srividya Viswanathan, Sarah Carothers, Bhuvaneswari Ramaswamy
Therapeutic Prospective: Clinical Investigation
-
Therapeutic potential of histone deacetylase inhibitors for breast cancer
Srividya Viswanathan, Sarah Carothers, Bhuvaneswari Ramaswamy
Therapeutic Prospective: Clinical Investigation
-
Therapeutic potential of histone deacetylase inhibitors for breast cancer
Srividya Viswanathan, Sarah Carothers, Bhuvaneswari Ramaswamy
Therapeutic Prospective: Clinical Investigation
-
Therapeutic potential of histone deacetylase inhibitors for breast cancer
Srividya Viswanathan, Sarah Carothers, Bhuvaneswari Ramaswamy
Therapeutic Prospective: Clinical Investigation
-
Therapeutic potential of histone deacetylase inhibitors for breast cancer
Srividya Viswanathan, Sarah Carothers, Bhuvaneswari Ramaswamy
Therapeutic Prospective: Clinical Investigation
-
Therapeutic potential of histone deacetylase inhibitors for breast cancer
Srividya Viswanathan, Sarah Carothers, Bhuvaneswari Ramaswamy
Therapeutic Prospective: Clinical Investigation
-
Therapeutic potential of histone deacetylase inhibitors for breast cancer
Srividya Viswanathan, Sarah Carothers, Bhuvaneswari Ramaswamy
Therapeutic Prospective: Clinical Investigation
-
Therapeutic potential of histone deacetylase inhibitors for breast cancer
Srividya Viswanathan, Sarah Carothers, Bhuvaneswari Ramaswamy
Therapeutic Prospective: Clinical Investigation